This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72079776
rdf:type
wikibase:Item
schema:description
im Mai 1993 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в травні 1993 artículu científicu espublizáu en mayu de 1993 scientific article published on 01 May 1993 article scientifique publié en 1993 գիտական հոդված հրատարակված 1993 թվականի մայիսի 1-ին
p:P577
wds:Q72079776-9093BF9D-741E-449C-A69E-ACBB78A8EFED
wdt:P577
1993-05-01T00:00:00Z
p:P2093
wds:Q72079776-77AECAF0-431B-4A7D-803A-A7A67F64DCDD wds:Q72079776-9ACE83DB-43F9-49BA-9619-6B046C0DDDD1 wds:Q72079776-B2713BF3-3797-4E42-AD27-A84862C69241 wds:Q72079776-37EED6B8-A33A-4903-A207-698A5469F32C wds:Q72079776-256EFFB0-14E0-420A-87E2-8FE9AA5F6A14 wds:Q72079776-4DA03105-A58C-4694-8A6F-9E0A00549C60 wds:Q72079776-6374211D-ADB2-4F51-A991-81910C3B7F0A wds:Q72079776-3B8E2E3D-31CD-4EFD-82B7-B10040BA5856 wds:Q72079776-F0E312F1-23AD-4B20-B1CE-569FFE71928C wds:Q72079776-F794B265-9991-4A5E-9E97-F5B553D6D578
wdt:P2093
B Nelson T J Lorenz L H Calabrese V Strand G W Cannon M L Lee N J Olsen C Wiesenhutter P E Lipsky S B Cohen
rdfs:label
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group
skos:prefLabel
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group
schema:name
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group
p:P1476
wds:Q72079776-43C7141A-795E-41ED-BD1E-14E69E550E47
wdt:P1476
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group
p:P304
wds:Q72079776-F7C79036-3690-4763-ADFD-AB31F22F59BC
wdt:P304
620-630
p:P31
wds:Q72079776-EB6E6259-1EAC-4806-A4FF-0C8002EE808F
wdt:P31
wd:Q13442814
p:P921
wds:Q72079776-3422297C-8592-4B5D-AFD3-665E9121CAC9
wdt:P921
wd:Q187255
p:P698
wds:Q72079776-EB4565B3-CAF8-4BE7-843D-0671611742FD
wdtn:P698
n7:7683881
wdt:P698
7683881
p:P1433
wds:Q72079776-65C2B754-8188-4ABD-8B5D-3D2F1A88FF54
wdt:P1433
wd:Q23929027
p:P433
wds:Q72079776-872B524C-45B0-4771-A358-C6AF4237F751
p:P478
wds:Q72079776-1F328E0E-CFD6-4D3A-B670-B8081DAFE341
wdt:P433
5
wdt:P478
36
p:P356
wds:Q72079776-323BC251-7EC4-4114-A862-A637DC1A81A5
wdtn:P356
n12:ART.1780360508
wdt:P356
10.1002/ART.1780360508